Stock market today: Dow, S&P 500, Nasdaq futures take a breather as shutdown drags on
US stock futures trod water on Friday after a retreat from record highs, as data-starved investors waited for a reprieve from the government shutdown that stretched into a 10th day.
Futures on the Dow Jones Industrial Average (YM=F), the S&P 500 (ES=F),
Read MoreRetirement planning for business owners
Business owners often focus on growth and reinvestment—but neglecting retirement planning can be a costly oversight. With 2025 contribution limits increased and new catch-up provisions in place, now is the time to act. This article from Comerica explores how to layer retirement plans, reduce taxes, and build long-term wealth.
Key takeaways:
-
401(k) contribution limits for 2025 are now $23,500,
» Read more about: Retirement planning for business owners »
Read MoreCryptocurrency Neither Promoted Nor Recognized in Pakistan: Federal Minister
Federal Minister Tariq Fazal Chaudhry informed the National Assembly that cryptocurrency is being regulated in Pakistan to prevent its misuse. During the question hour session, he clarified that the government neither promotes nor discourages cryptocurrency, emphasizing that it is not yet a recognized currency in the country.
The minister said that necessary regulations are being introduced to curb illegal activities and misuse associated with digital currencies.
» Read more about: Cryptocurrency Neither Promoted Nor Recognized in Pakistan: Federal Minister »
Read MoreThe buyback trend in the cryptocurrency market – Using Wall Street’s oldest trick in the book
Token buyback is one of the latest trends in the broader cryptocurrency market in 2025, similar to stock buybacks on Wall Street but with several key differences. Shaking the demand-supply scales, multiple blue-chip altcoins are adjusting their tokenomics through buybacks to build native reserves, corporate reserves, or by burning their own tokens. To gain further insights into token buybacks,
Read MoreLuxembourg Sovereign Wealth Fund Announces 1% Portfolio Allocation to Bitcoin ETFs
The Luxembourg sovereign wealth fund has reportedly invested 1% of its portfolio into Bitcoin ETFs, which is said to make it the first sovereign wealth fund in the Eurozone area to officially gain exposure to Bitcoin.
With the update, Luxembourg appears to be asserting its position as a first-mover among Eurozone countries by having its Intergenerational Sovereign Wealth Fund (FSIL) allocate 1% of its overall investment portfolio to Bitcoin ETFs.
Read MoreThe Burst
Pfizer’s Big Win Means What For Investors?
Pfizer just pulled off a big deal as it relates to the pharmaceutical landscape in the U.S. On Tuesday, the CEO announced a wide-ranging agreement with the Trump administration that will lower drug prices for many Americans.
At the center of this deal is a new government-backed portal called “TrumpRx”, a website designed to help patients access discounted prescription drugs by connecting them directly to manufacturers’ platforms.
» Read more about: Pfizer’s Big Win Means What For Investors? »
Read MoreThe Ivy
Is Micron’s AI Gold Rush a Perfect Storm?
Micron Technology soared by more than 42.98% over the last 30 days, a jaw-dropping rally even by tech’s feverish standards. The reason? Artificial intelligence and specifically, the voracious appetite for memory chips powering the world’s new AI data centers.
But beneath the surface of the AI euphoria, do the fundamentals justify the soaring share price?
» Read more about: Is Micron’s AI Gold Rush a Perfect Storm? »
Read MoreThe Spotlight
Why Novo May Be the Real Winner in Obesity Drug Boom
For decades, Novo Nordisk was known mainly within the medical community as a quiet Danish powerhouse in diabetes care. Fast-forward to today, and its brand names are practically pop culture references. Wegovy and Ozempic have become synonymous with rapid weight loss, with late-night comedians, TikTok influencers, and even Hollywood scripts weaving them into conversation. Yet the company’s stock,
» Read more about: Why Novo May Be the Real Winner in Obesity Drug Boom »